From Wikipedia, the free encyclopedia
The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.

The result was keep. ( non-admin closure) MrScorch6200 ( talk | ctrb) 00:23, 17 February 2014 (UTC) reply

Cold-fX

Cold-fX (  | talk | history | protect | delete | links | watch | logs | views) – ( View log · Stats)
(Find sources:  Google ( books · news · scholar · free images · WP refs· FENS · JSTOR · TWL)

Article was recently tagged for notability. Since it has been around a while and has sources, I am taking it into AfD to decide the issue. If there is a quick consensus in favor of delete, oops, keep, I will withdraw the nomination and close early, but better than leaving a notability tag on the article indefinitely. I lean slightly to delete, but I won't press the issue if the consensus goes the other way. Safiel ( talk) 21:53, 22 January 2014 (UTC) reply

Note: This debate has been included in the list of Medicine-related deletion discussions. Northamerica1000 (talk) 16:58, 23 January 2014 (UTC) reply
Note: This debate has been included in the list of Business-related deletion discussions. Northamerica1000 (talk) 16:59, 23 January 2014 (UTC) reply

Relisted to generate a more thorough discussion so a clearer consensus may be reached.
Please add new comments below this notice. Thanks, Northamerica1000 (talk) 16:23, 30 January 2014 (UTC) reply


Relisted to generate a more thorough discussion so a clearer consensus may be reached.
Please add new comments below this notice. Thanks, Northamerica1000 (talk) 12:46, 10 February 2014 (UTC) reply

  • Keep Keep as the product is notable, the COI editing should be dealt with either page protection or aggressive monitoring. Mrfrobinson ( talk) 20:30, 10 February 2014 (UTC) reply
  • Keep Merging with American ginseng does not make sense to me since most people looking for this article would not know to look under ginseng. There have been no edits since it came off protection in late December so there is no current issue with COI edits. If anything, the article is currently unbalanced to the negative side. The product has had widespread distribution and media coverage in Canada and seems notable to me, whether it works or not. Meters ( talk) 21:41, 10 February 2014 (UTC) reply
  • Keep - Passes WP:GNG. Source examples:
  • "Fighting the Common Cold". ABC News. 2005-10-25.
  • Does Cold-FX work instantly as claimed? - Canada - CBC News
  • Paladin Labs' Afexa Sciences Hostile Takeover Bid Worth $56.7 Million
  • Health Canada approves Cold-fX's medical claims | CTV News
  • Battle brews to take over Cold-FX maker Afexa - The Globe and Mail
  • UBC professors question effectiveness of Cold-fX
  • Q&A: The Doctor Who Created Cold-FX | Health Media Today
  • Cold-FX maker has failed to deliver on promises: Paladin | Financial Post
  • Charlie Gillis (2007-03-26). "COLD-fX catches the sniffles again". Macleans Magazine.
 – Northamerica1000 (talk) 00:09, 11 February 2014 (UTC) reply
  • Keep - Passes WP:GNG. See reference improvements and additional sources added to article (under "Further reading") by Northamerica1000 - tucoxn\ talk 05:40, 12 February 2014 (UTC) reply
The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.
From Wikipedia, the free encyclopedia
The following discussion is an archived debate of the proposed deletion of the article below. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.

The result was keep. ( non-admin closure) MrScorch6200 ( talk | ctrb) 00:23, 17 February 2014 (UTC) reply

Cold-fX

Cold-fX (  | talk | history | protect | delete | links | watch | logs | views) – ( View log · Stats)
(Find sources:  Google ( books · news · scholar · free images · WP refs· FENS · JSTOR · TWL)

Article was recently tagged for notability. Since it has been around a while and has sources, I am taking it into AfD to decide the issue. If there is a quick consensus in favor of delete, oops, keep, I will withdraw the nomination and close early, but better than leaving a notability tag on the article indefinitely. I lean slightly to delete, but I won't press the issue if the consensus goes the other way. Safiel ( talk) 21:53, 22 January 2014 (UTC) reply

Note: This debate has been included in the list of Medicine-related deletion discussions. Northamerica1000 (talk) 16:58, 23 January 2014 (UTC) reply
Note: This debate has been included in the list of Business-related deletion discussions. Northamerica1000 (talk) 16:59, 23 January 2014 (UTC) reply

Relisted to generate a more thorough discussion so a clearer consensus may be reached.
Please add new comments below this notice. Thanks, Northamerica1000 (talk) 16:23, 30 January 2014 (UTC) reply


Relisted to generate a more thorough discussion so a clearer consensus may be reached.
Please add new comments below this notice. Thanks, Northamerica1000 (talk) 12:46, 10 February 2014 (UTC) reply

  • Keep Keep as the product is notable, the COI editing should be dealt with either page protection or aggressive monitoring. Mrfrobinson ( talk) 20:30, 10 February 2014 (UTC) reply
  • Keep Merging with American ginseng does not make sense to me since most people looking for this article would not know to look under ginseng. There have been no edits since it came off protection in late December so there is no current issue with COI edits. If anything, the article is currently unbalanced to the negative side. The product has had widespread distribution and media coverage in Canada and seems notable to me, whether it works or not. Meters ( talk) 21:41, 10 February 2014 (UTC) reply
  • Keep - Passes WP:GNG. Source examples:
  • "Fighting the Common Cold". ABC News. 2005-10-25.
  • Does Cold-FX work instantly as claimed? - Canada - CBC News
  • Paladin Labs' Afexa Sciences Hostile Takeover Bid Worth $56.7 Million
  • Health Canada approves Cold-fX's medical claims | CTV News
  • Battle brews to take over Cold-FX maker Afexa - The Globe and Mail
  • UBC professors question effectiveness of Cold-fX
  • Q&A: The Doctor Who Created Cold-FX | Health Media Today
  • Cold-FX maker has failed to deliver on promises: Paladin | Financial Post
  • Charlie Gillis (2007-03-26). "COLD-fX catches the sniffles again". Macleans Magazine.
 – Northamerica1000 (talk) 00:09, 11 February 2014 (UTC) reply
  • Keep - Passes WP:GNG. See reference improvements and additional sources added to article (under "Further reading") by Northamerica1000 - tucoxn\ talk 05:40, 12 February 2014 (UTC) reply
The above discussion is preserved as an archive of the debate. Please do not modify it. Subsequent comments should be made on the appropriate discussion page (such as the article's talk page or in a deletion review). No further edits should be made to this page.

Videos

Youtube | Vimeo | Bing

Websites

Google | Yahoo | Bing

Encyclopedia

Google | Yahoo | Bing

Facebook